|
Not yet recruiting
|
NCT05286255 -
Mesenchymal Stromal Cells for COVID-19 and Viral Pneumonias
|
Phase 1 |
|
Recruiting
|
NCT04952337 -
Clinical, Molecular and Functional Biomarkers for PROgnosis, Pathomechanisms and Treatment Strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ)
|
|
|
Completed
|
NCT04606407 -
Inhaled NO for the Treatment of Viral Pneumonia in Adults
|
N/A |
|
Not yet recruiting
|
NCT05612893 -
Discover the Immune Signature of Sepsis Caused by Acute Pulmonary Infection: A Cohort Study
|
|
|
Not yet recruiting
|
NCT04397497 -
Mavrilimumab in Severe COVID-19 Pneumonia and Hyper-inflammation (COMBAT-19)
|
Phase 2 |
|
Terminated
|
NCT04345289 -
Efficacy and Safety of Novel Treatment Options for Adults With COVID-19 Pneumonia
|
Phase 3 |
|
Enrolling by invitation
|
NCT04326036 -
Use of cSVF Via IV Deployment for Residual Lung Damage After Symptomatic COVID-19 Infection
|
Early Phase 1 |
|
Withdrawn
|
NCT00645619 -
Use of TREM-1 Protein to Differentiate Viral and Bacterial Pneumonias in Intubated Children
|
|
|
Completed
|
NCT04385823 -
Use of High Flow Nasal Cannula Oxygen and Covid-19 Acute Hypoxemic Respiratory Failure
|
|
|
Not yet recruiting
|
NCT04876573 -
Pilot Study for Cyproheptadine in Hospitalized Patient for COVID-19
|
Phase 2 |
|
Unknown status
|
NCT01612572 -
A Registry Study on Xiyanping(a Chinese Medicine Injection) Used in Fifty Hospitals
|
N/A |
|
Completed
|
NCT02152358 -
PTH - Preemptive Treatment for Herpesviridae
|
Phase 4 |
|
Completed
|
NCT04644302 -
Circulatory Coherence in COVID-19 and Non-COVID-19 Patients With Sepsis
|
|
|
Recruiting
|
NCT05531149 -
Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia
|
Phase 3 |
|
Not yet recruiting
|
NCT04955223 -
Yinhu Qingwen Granule in the Treatment of Viral Pneumonia
|
Early Phase 1 |
|
Completed
|
NCT01868113 -
Inhaled Corticosteroids in U-5 Children With Acute Respiratory Infection in Uganda: A Randomised Trial
|
Phase 3 |
|
Recruiting
|
NCT04380376 -
Low-doses Melphalan Inhalation in Patients With COVID-19 (CoronavIrus Disease 2019) Pneumonia
|
Phase 2 |
|
Completed
|
NCT05386459 -
Study of the Use of the Drug Ingaron in Patients With COVID-19
|
|
|
Not yet recruiting
|
NCT06349707 -
Multiplex PCR for Severe Respiratory Infections During the COVID-19 Pandemic
|
|
|
Completed
|
NCT04394026 -
Imaging Feature of SARS-CoV2 Infection
|
|